Ariad's sales of Iclusig rise 22 percent, but not enough for most analysts

As the number of doctors who have prescribed Ariad Pharmaceuticals' leukemia drug has jumped in recent months, sales of the drug also increased, though not as quickly...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.